Press Releases
Sen. Lee, Rep. Buck Question Big Tech CEOs on Actions Against Parler
Apr 1, 2021
WASHINGTON – Sen. Mike Lee (R-Utah) and Rep. Ken Buck (R-Colo.) on Wednesday sent a letter to the CEOs of Google, Apple, and Amazon questioning a series of actions their companies took against Parler.
The letter reads in part:
“As detailed in the timeline below, the timing of steps taken against the Parler social network by your companies and that the actions seem to lack any of the procedural fairness typically afforded in the case of an alleged breach of contract create the appearance of close coordination.
ICYMI: Sen. Lee Visits Mexico Border, Calls for End to Crisis
Mar 29, 2021
Last week, Sen. Mike Lee (R-Utah) joined a congressional delegation trip with 17 of his colleagues to help shed light on the humanitarian crisis caused by the recent surges in illegal immigration along the U.S.-Mexico border. The senators toured immigration processing facilities along the border, attended a roundtable with local leaders, and heard firsthand accounts of the journeys of migrant men, women, and children.
Sen. Lee Cosponsors the Smarter Sentencing Act
Mar 26, 2021
WASHINGTON – Sen. Mike Lee (R-Utah) cosponsored the “Smarter Sentencing Act,” bipartisan legislation designed to bring judicial discretion and flexibility to non-violent drug charge sentencing. The bill is sponsored by Sen. Dick Durbin (D- Ill.) and cosponsored by 11 of their colleagues.
Since 1980, the number of inmates in federal prison has increased by 653%. About 50% of those federal inmates are serving sentences for drug-related offenses, increasing the taxpayer burden by more than 2,000%. In short, federal incarceration has become one of our nation’s biggest expenditures, dwarfing the amount spent on law enforcement.
Sen. Lee, Colleagues Urge HHS to Expand Ethical Sources of Fetal Tissue
Mar 26, 2021
WASHINGTON – Sen. Mike Lee (R-Utah) on Friday led 15 of his colleagues in sending a letter to the Secretary of Health and Human Services (HHS) requesting that the agency evaluate its ability to expand the existing organ donation network to include preterm and stillborn infant donors, so as to provide an ethical alternative to aborted fetal tissue. Under no circumstance should scientific research and experimentation use cells or tissues derived from abortion.
The letter reads in part:
“Respecting the dignity of human life from conception to natural death is critically important and this action would be a significant step toward protecting human life at all stages. If a consistent, high-quality, and ethically uncontroversial source of human fetal tissue exists, medical research would undoubtedly expand, advancing our nation’s understanding of human development and leading to potentially life-saving discoveries.”
